Thermogenesis Holdings Inc
F:THR

Watchlist Manager
Thermogenesis Holdings Inc Logo
Thermogenesis Holdings Inc
F:THR
Watchlist
Price: 1.62 EUR Market Closed
Market Cap: €4m

Thermogenesis Holdings Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Thermogenesis Holdings Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Thermogenesis Holdings Inc
F:THR
Research & Development
-$1.2m
CAGR 3-Years
19%
CAGR 5-Years
14%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Research & Development
-$2.1B
CAGR 3-Years
-16%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Stryker Corp
NYSE:SYK
Research & Development
-$1.6B
CAGR 3-Years
-8%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
Abbott Laboratories
NYSE:ABT
Research & Development
-$2.8B
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
-8%
IDEXX Laboratories Inc
NASDAQ:IDXX
Research & Development
-$251.2m
CAGR 3-Years
0%
CAGR 5-Years
-12%
CAGR 10-Years
-10%
Intuitive Surgical Inc
NASDAQ:ISRG
Research & Development
-$1.3B
CAGR 3-Years
-15%
CAGR 5-Years
-18%
CAGR 10-Years
-21%
No Stocks Found

Thermogenesis Holdings Inc
Glance View

Market Cap
4m EUR
Industry
Health Care

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 39 full-time employees. The firm provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for large scale cell manufacturing services. The company manufactures and markets three categories of products, Clinical Bio-Banking Applications, Point-of-Care Applications, and Large Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications includes AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Point-of-Care Applications includes PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory useand CAR-TXpress Platform for clinical manufacturing.

THR Intrinsic Value
Not Available

See Also

What is Thermogenesis Holdings Inc's Research & Development?
Research & Development
-1.2m USD

Based on the financial report for Mar 31, 2024, Thermogenesis Holdings Inc's Research & Development amounts to -1.2m USD.

What is Thermogenesis Holdings Inc's Research & Development growth rate?
Research & Development CAGR 10Y
9%

Over the last year, the Research & Development growth was 21%. The average annual Research & Development growth rates for Thermogenesis Holdings Inc have been 19% over the past three years , 14% over the past five years , and 9% over the past ten years .

Back to Top